Skip to main content
. 2021 Nov 3;4(11):e2131674. doi: 10.1001/jamanetworkopen.2021.31674

Table 2. Descriptive Statistics for Patients With Hidden Hypoxemia vs Patients Without Hypoxemiaa.

Characteristic Asian patients, mean (SE) P value Black patients, mean (SE) P value Hispanic patients, mean (SE) P value White patients, mean (SE) P value
Hidden hypoxemia No hypoxemia Hidden hypoxemia No hypoxemia Hidden hypoxemia No hypoxemia Hidden hypoxemia No hypoxemia
No. (%) 94 (4.9) 1825 (95.1) NA 1789 (6.9) 24 243 (93.1) NA 145 (6.0) 2252 (94.0) NA 2831 (4.9) 54 792 (95.1) NA
Age, y 63.93 (2.46) 62.34 (0.51) <.001 58.26 (0.51) 57.76 (0.15) <.001 57.48 (2.05) 59.53 (0.52) <.001 64.03 (0.41) 64.29 (0.1) <.001
Sex, No. (%)
Female 36 (38.3) 724 (39.7) .89 862 (48.2) 11 243 (46.4) .11 75 (51.7) 1028 (45.6) .15 1241 (43.8) 22 504 (41.1) .01
Male 58 (61.7) 1101 (60.3) 927 (51.8) 13 000 (53.6) 70 (48.3) 1224 (54.4) 1590 (56.2) 32 288 (58.9)
Serum creatinine levels, mg/dL
Before ABG 1.73 (0.24) 1.59 (0.07) <.001 2.37 (0.09) 2.27 (0.03) <.001 1.79 (0.19) 1.66 (0.04) <.001 1.73 (0.04) 1.46 (0.01) <.001
After ABG 1.79 (0.31) 1.44 (0.06) <.001 2.2 (0.08) 2.07 (0.02) <.001 2.01 (0.33) 1.6 (0.07) <.001 1.53 (0.06) 1.38 (0.01) <.001
Difference 0.05 (0.19) −0.1 (0.04) <.001 −0.21 (0.06) −0.2 (0.02) .08 −0.15 (0.19) −0.17 (0.04) .33 −0.17 (0.05) −0.07 (0.01) <.001
Serum lactate levels, mg/dL
Before ABG 4.37 (0.82) 2.87 (0.11) <.001 3.4 (0.13) 2.85 (0.03) <.001 2.96 (0.45) 2.87 (0.09) .26 2.99 (0.1) 2.56 (0.02) <.001
After ABG 2.97 (0.65) 2.32 (0.15) <.001 3.27 (0.22) 2.5 (0.04) <.001 3.4 (0.8) 2.24 (0.13) <.001 2.51 (0.14) 2.15 (0.03) <.001
Difference, −1.61 (0.86) −1.14 (0.2) <.001 −0.34 (0.25) −0.82 (0.05) <.001 −0.41 (0.79) −1.14 (0.18) <.001 −0.68 (0.2) −0.74 (0.04) .00
Long-term clinical outcomes
Hospital LOS, db 13.63 (1.81) 13.18 (0.5) .02 13.51 (0.58) 16.48 (0.18) .00 14.01 (2.11) 13.18 (0.56) .00 10.67 (0.35) 11.19 (0.07) .00
In-hospital death, No. (%) 20 (21.3) 286 (15.7) .13 369 (20.6) 3557 (14.7) <.001 35 (24.1) 439 (19.5) .06 738 (26.1) 8238 (15.0) <.001
SOFA scorec
At the time of ABG
CVSOFA 0.61 (0.2) 0.73 (0.06) <.001 0.98 (0.07) 0.85 (0.02) <.001 1.05 (0.15) 1.03 (0.03) .14 1.13 (0.03) 0.99 (0.01) <.001
RSOFA 1.56 (0.32) 1.26 (0.06) <.001 1.87 (0.12) 1.4 (0.03) <.001 2.02 (0.17) 1.44 (0.04) <.001 1.81 (0.04) 1.38 (0.01) <.001
SOFA 6.03 (0.75) 5.82 (0.15) <.001 4.98 (0.25) 5.26 (0.06) <.001 5.09 (0.54) 5.37 (0.09) <.001 5.27 (0.1) 5.22 (0.03) <.001
24 h After ABG
CVSOFA 1.52 (0.2) 1.36 (0.05) <.001 7.02 (0.29) 6.33 (0.07) <.001 1.56 (0.15) 1.32 (0.03) <.001 1.48 (0.03) 1.26 (0.01) <.001
RSOFA 1.58 (0.28) 1.27 (0.07) <.001 1.87 (0.1) 1.4 (0.03) <.001 2.01 (0.18) 1.45 (0.04) <.001 1.79 (0.04) 1.37 (0.01) <.001
SOFA 7.17 (0.77) 5.62 (0.17) <.001 8.17 (0.27) 7.26 (0.08) <.001 7.49 (0.54) 6.3 (0.1) <.001 7.2 (0.1) 6.3 (0.02) <.001

Abbreviations: ABG, arterial blood gas; CVSOFA, cardiovascular Sequential Organ Failure Assessment; LOS, length of stay; NA, not applicable; RSOFA, respiratory Sequential Organ Failure Assessment; SOFA, Sequential Organ Failure Assessment.

SI conversion factors: To convert creatinine to micromoles per liter, multiply by 88.4; lactate to millimoles per liter, multiply by 0.111.

a

The table presents baseline patient demographic (age, sex) and clinical characteristics (SOFA, CVSOFA) at the time of ABG, stratified by race and ethnicity. When applicable, SEs are provided. These were obtained using simple bootstrap with 100 iterations.

b

Length of stay computed for survivors only.

c

SOFA scores available only for patients in the Electronic Intensive Care Unit–Clinical Research Database and Medical Information Mart for Intensive Care databases.